BlackRock Fund Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.9M | Buy |
399,317
+50,951
| +15% | +$242K | ﹤0.01% | 3173 |
|
|
2016
Q3 | $2.3M | Buy |
348,366
+17,358
| +5% | +$115K | ﹤0.01% | 3128 |
|
|
2016
Q2 | $1.81M | Buy |
331,008
+30,400
| +10% | +$166K | ﹤0.01% | 3208 |
|
|
2016
Q1 | $6.43M | Sell |
300,608
-13,215
| -4% | -$283K | ﹤0.01% | 2607 |
|
|
2015
Q4 | $9.92M | Buy |
313,823
+14,033
| +5% | +$443K | ﹤0.01% | 2451 |
|
|
2015
Q3 | $10.3M | Buy |
299,790
+38,043
| +15% | +$1.31M | ﹤0.01% | 2359 |
|
|
2015
Q2 | $8.24M | Buy |
261,747
+20,985
| +9% | +$660K | ﹤0.01% | 2618 |
|
|
2015
Q1 | $7.06M | Buy |
240,762
+43,091
| +22% | +$1.26M | ﹤0.01% | 2637 |
|
|
2014
Q4 | $3.66M | Buy |
197,671
+28,098
| +17% | +$520K | ﹤0.01% | 3022 |
|
|
2014
Q3 | $2.97M | Sell |
169,573
-6,977
| -4% | -$122K | ﹤0.01% | 3029 |
|
|
2014
Q2 | $3.53M | Buy |
+176,550
| New | +$3.53M | ﹤0.01% | 3016 |
|